p38 mitogen-activated protein kinase pathways in asthma and COPD.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Chest

• Publication date

  2011-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1378/chest.10-1914PMID 21652557
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Inhibition of p38 MAPK-dependent bronchial contraction after ozone by corticosteroids

  2010cited by this paper
• A Benzothiophene Inhibitor of Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Inhibits Tumor Necrosis Factor α Production and Has Oral Anti-Inflammatory Efficacy in Acute and Chronic Models of Inflammation

  2010cited by this paper
• The tyrosine phosphatase, SHP-1, is involved in bronchial mucin production during oxidative stress.

  2010cited by this paper
• Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation.

  2010cited by this paper
• A Randomized, Placebo‐Controlled Study of the Effects of the p38 MAPK Inhibitor SB‐681323 on Blood Biomarkers of Inflammation in COPD Patients

  2010cited by this paper
• Crucial implication of protein kinase C (PKC)‐δ, PKC‐ζ, ERK‐1/2, and p38 MAPK in migration of human asthmatic eosinophils

  2009cited by this paper
• Structural bioinformatics-based prediction of exceptional selectivity of p38 MAP kinase inhibitor PH-797804.

  2009cited by this paper
• Evaluation of the efficacy and safety of pamapimod, a p38 MAP kinase inhibitor, in a double-blind, methotrexate-controlled study of patients with active rheumatoid arthritis.

  2009cited by this paper
• The p38 MAPK pathway inhibits tristetraprolin‐directed decay of interleukin‐10 and pro‐inflammatory mediator mRNAs in murine macrophages

  2009cited by this paper
• “Go upstream, young man”: lessons learned from the p38 saga

  2009cited by this paper
• Effect of p38 MAPK inhibition on corticosteroid suppression of cytokine release in severe asthma

  2009cited by this paper
• alpha,beta-Unsaturated aldehydes contained in cigarette smoke elicit IL-8 release in pulmonary cells through mitogen-activated protein kinases.

  2009cited by this paper
• Inhaled corticosteroids as combination therapy with β-adrenergic agonists in airways disease: present and future

  2009cited by this paper
• Efficacy, pharmacodynamics, and safety of VX-702, a novel p38 MAPK inhibitor, in rheumatoid arthritis: results of two randomized, double-blind, placebo-controlled clinical studies.

  2009cited by this paper
• Cigarette smoke extract induces cytosolic phospholipase A2 expression via NADPH oxidase, MAPKs, AP-1, and NF-κB in human tracheal smooth muscle cells

  2009cited by this paper
• Inflammatory biomarkers in airways of patients with severe asthma compared with non‐severe asthma

  2009cited by this paper
• Cigarette smoke extract induces cytosolic phospholipase A2 expression via NADPH oxidase, MAPKs, AP-1, and NF-kappaB in human tracheal smooth muscle cells.

  2009cited by this paper
• Regulation of the RelA (p65) transactivation domain.

  2008cited by this paper
• p38α-Selective Mitogen-Activated Protein Kinase Inhibitor SD-282 Reduces Inflammation in a Subchronic Model of Tobacco Smoke-Induced Airway Inflammation

  2008cited by this paper
• Impact of tobacco‐smoke on key signaling pathways in the innate immune response in lung macrophages

  2008cited by this paper
• Analysis of gene expression in human bronchial epithelial cells upon influenza virus infection and regulation by p38 mitogen‐activated protein kinase and c‐Jun‐N‐terminal kinase

  2008cited by this paper
• Increased activation of p38 MAPK in COPD

  2008cited by this paper
• Human rhinovirus infection enhances airway epithelial cell production of growth factors involved in airway remodeling.

  2008cited by this paper
• Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways.

  2008cited by this paper
• Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared with non-severe asthma

  2008cited by this paper
• Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction

  2008cited by this paper
• Role of p38 mitogen-activated protein kinase in ozone-induced airway hyperresponsiveness and inflammation.

  2008cited by this paper
• Corticosteroids reduce IL-6 in ASM cells via up-regulation of MKP-1.

  2008cited by this paper
• Corticosteroid Inhibition of Growth-Related Oncogene Protein-α via Mitogen-Activated Kinase Phosphatase-1 in Airway Smooth Muscle Cells1

  2007cited by this paper
• p38alpha antagonizes p38gamma activity through c-Jun-dependent ubiquitin-proteasome pathways in regulating Ras transformation and stress response.

  2007cited by this paper
• Constitutive and inducible thymic stromal lymphopoietin expression in human airway smooth muscle cells: role in chronic obstructive pulmonary disease.

  2007cited by this paper
• Feedback control of MKP-1 expression by p38.

  2007cited by this paper
• p38α Antagonizes p38γ Activity through c-Jun-dependent Ubiquitin-proteasome Pathways in Regulating Ras Transformation and Stress Response*

  2007cited by this paper
• Corrigendum to “Feedback control of MKP-1 expression by p38” [Cell Signal 2007; 19: 393–400]

  2007cited by this paper
• Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1

  2006cited by this paper
• Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-α in human monocytes

  2006cited by this paper
• CXCL12 and C5a trigger cell migration via a PAK1/2-p38alpha MAPK-MAPKAP-K2-HSP27 pathway.

  2006cited by this paper
• Kinase inhibitors and airway inflammation.

  2006cited by this paper
• IL-17A acts via p38 MAPK to increase stability of TNF-alpha-induced IL-8 mRNA in human ASM.

  2006cited by this paper
• Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression

  2006cited by this paper
• Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma.

  2006cited by this paper
• Oral p38 mitogen-activated protein kinase inhibition with BIRB 796 for active Crohn's disease: a randomized, double-blind, placebo-controlled trial.

  2006cited by this paper
• IL-17A acts via p38 MAPK to increase stability of TNF-α-induced IL-8 mRNA in human ASM

  2006cited by this paper
• Importance of p38 mitogen-activated protein kinase pathway in allergic airway remodelling and bronchial hyperresponsiveness.

  2006cited by this paper
• Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-alpha in human monocytes.

  2006cited by this paper
• Inhibitory effect of p38 mitogen‐activated protein kinase inhibitors on cytokine release from human macrophages

  2006cited by this paper
• The role of caldesmon in the regulation of endothelial cytoskeleton and migration

  2005cited by this paper
• Alternative p38 activation pathway mediated by T cell receptor–proximal tyrosine kinases

  2005cited by this paper
• Inhaled p38alpha mitogen-activated protein kinase antisense oligonucleotide attenuates asthma in mice.

  2005cited by this paper
• The Role of p38 MAPK in Rhinovirus-Induced Monocyte Chemoattractant Protein-1 Production by Monocytic-Lineage Cells1

  2005cited by this paper
• p38 Mitogen-activated protein kinase (MAPK) is a key mediator in glucocorticoid-induced apoptosis of lymphoid cells: correlation between p38 MAPK activation and site-specific phosphorylation of the human glucocorticoid receptor at serine 211.

  2005cited by this paper
• Effect of smoking on MAP kinase-induced modulation of IL‐8 in human alveolar macrophages

  2004cited by this paper
• Mitogen‐activated protein kinase signalling pathways in IL‐1β‐dependent rat airway smooth muscle proliferation

  2004cited by this paper
• Inhibition of Glucocorticoid Receptor-mediated Transcriptional Activation by p38 Mitogen-activated Protein (MAP) Kinase*

  2004cited by this paper
• Mitogen-activated protein kinase modulation of nuclear factor-kappaB-induced granulocyte macrophage-colony-stimulating factor release from human alveolar macrophages.

  2004cited by this paper
• Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function.

  2004cited by this paper
• Lipopolysaccharide Induces Matrix Metalloproteinase-9 Expression via a Mitochondrial Reactive Oxygen Species-p38 Kinase-Activator Protein-1 Pathway in Raw 264.7 Cells1

  2004cited by this paper
• Histone acetylase and deacetylase activity in alveolar macrophages and blood mononocytes in asthma.

  2004cited by this paper
• Interleukin 1α (IL-1α) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function

  2004cited by this paper
• IL-17A augments TNF-alpha-induced IL-6 expression in airway smooth muscle by enhancing mRNA stability.

  2004cited by this paper
• Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease.

  2003cited by this paper
• JNK and p38 MAP kinases in CD4+ and CD8+ T cells

  2003cited by this paper
• MAPK regulation of gene expression in airway smooth muscle.

  2003cited by this paper
• An efficient proteomics method to identify the cellular targets of protein kinase inhibitors

  2003cited by this paper
• p38 Mitogen-activated protein kinases on the body surface--a function for p38 delta.

  2003cited by this paper
• p38 Mitogen-Activated Protein Kinases on the Body Surface – A Function for p38δ

  2003cited by this paper
• p38 Isoforms Have Opposite Effects on AP-1-dependent Transcription through Regulation of c-Jun

  2003cited by this paper
• Interleukin-3, -5, and granulocyte macrophage colony-stimulating factor-induced adhesion molecule expression on eosinophils by p38 mitogen-activated protein kinase and nuclear factor-[kappa] B.

  2003cited by this paper
• An intracellular signaling hierarchy determines direction of migration in opposing chemotactic gradients

  2002cited by this paper
• Inhibition of the p38 MAP kinase pathway destabilizes smooth muscle length during physiological loading.

  2002cited by this paper
• Biologic effects induced in vitro by PM10 from three different zones of Mexico City.

  2002cited by this paper
• Activation of p38 MAP-Kinase and Caldesmon Phosphorylation Are Essential for Urokinase-Induced Human Smooth Muscle Cell Migration

  2002cited by this paper
• p38-dependent marking of inflammatory genes for increased NF-κB recruitment

  2002cited by this paper
• p38-Dependent marking of inflammatory genes for increased NF-kappa B recruitment.

  2002cited by this paper
• Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases

  2002cited by this paper
• Anti-Inflammatory Effects of a p38 Mitogen-Activated Protein Kinase Inhibitor During Human Endotoxemia1

  2002cited by this paper
• p38 Mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma.

  2002cited by this paper
• Tumor necrosis factor receptor (TNFR) 1, but not TNFR2, mediates tumor necrosis factor-alpha-induced interleukin-6 and RANTES in human airway smooth muscle cells: role of p38 and p42/44 mitogen-activated protein kinases.

  2001cited by this paper
• VX-745. Vertex Pharmaceuticals.

  2001cited by this paper
• Inhibitors of mitogen-activated protein kinases differentially regulate eosinophil-activating cytokine release from human airway smooth muscle.

  2001cited by this paper
• A Critical Role for p38 Mitogen-Activated Protein Kinase in the Maturation of Human Blood-Derived Dendritic Cells Induced by Lipopolysaccharide, TNF-α, and Contact Sensitizers

  2001cited by this paper
• VX-745. Vertex Pharmaceuticals.

  2001cited by this paper
• Sensitized Mast Cells Migrate Toward the Agen: A Response Regulated by p38 Mitogen-Activated Protein Kinase and Rho-Associated Coiled-Coil-Forming Protein Kinase1

  2001cited by this paper
• SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung.

  2000cited by this paper
• p38 MAP kinase and MKK‐1 co‐operate in the generation of GM‐CSF from LPS‐stimulated human monocytes by an NF‐κB‐independent mechanism

  2000cited by this paper
• Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes.

  2000cited by this paper
• SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence.

  2000cited by this paper
• Airway smooth muscle cells: contributing to and regulating airway mucosal inflammation?

  2000cited by this paper
• The Differential Role of Extracellular Signal-Regulated Kinases and p38 Mitogen-Activated Protein Kinase in Eosinophil Functions1

  2000cited by this paper
• A role for p38(MAPK)/HSP27 pathway in smooth muscle cell migration.

  1999cited by this paper
• A Role for p38MAPK/HSP27 Pathway in Smooth Muscle Cell Migration*

  1999cited by this paper
• Neutrophilic inflammation in severe persistent asthma.

  1999cited by this paper
• Impaired on/off regulation of TNF biosynthesis in mice lacking TNF AU-rich elements: implications for joint and gut-associated immunopathologies.

  1999cited by this paper
• C-reactive Protein Inhibits Chemotactic Peptide-induced p38 Mitogen-activated Protein Kinase Activity and Human Neutrophil Movement*

  1999cited by this paper
• SB 203580, an inhibitor of p38 mitogen-activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils.

  1999cited by this paper
• Heat shock protein 27 kDa expression and phosphorylation regulates endothelial cell migration

  1998cited by this paper
• Identification of stathmin as a novel substrate for p38 delta.

  1998cited by this paper
• Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells.

  1997cited by this paper
• Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle.

  1997cited by this paper
• Phosphorylation of the 27-kDa heat shock protein via p38 MAP kinase and MAPKAP kinase in smooth muscle.

  1997cited by this paper

• Anti-asthmatic potential of Rudanti (Capparis moonii Wight): Integrated metabolomics and network pharmacology approach for identifying lead molecule, associated pharmacological mechanisms, and ex-vivo experimental studies

  2025cites this paper
• Hederasaponin C ameliorates chronic obstructive pulmonary disease pathogenesis by targeting TLR4 to inhibit NF-κB/MAPK signaling pathways

  2025cites this paper
• A combination of alveolar type 2–specific p38α activation with a high-fat diet increases inflammatory markers in mouse lungs

  2025cites this paper
• Eosinophil-targeted treatment strategies for long-term outcomes in severe eosinophilic asthma

  2025cites this paper
• Childhood Asthma Biomarkers Derived from Plasma and Saliva Exosomal miRNAs

  2025cites this paper
• Synthesis, anti-allergic rhinitis evaluation and mechanism investigation of novel 1,2,4-triazole-enamides as CB1 R antagonist.

  2025cites this paper
• Oxidative stress in asthma pathogenesis: mechanistic insights and implications for airway smooth muscle dysfunction

  2025influential citation
• Molecular Study from the Signaling Pathways of Four Potential asthma triggers: AKT1, MAPK13, STAT1, and TLR4

  2025cites this paper
• MPSO-CD: A Multi-Objective Particle Swarm Optimization Community Detection Method for Identifying Disease Modules

  2025cites this paper
• FUNDC1 Promoted Ferroptosis via JNK Pathway in Cigarette Smoking-Induced Chronic Obstructive Pulmonary Disease

  2025cites this paper
• Effects of Tibetan medicine Longdan zhike tablet on chronic obstructive pulmonary disease through MAPK pathway.

  2024cites this paper
• Eosinophilic Asthma: Pathophysiology and Therapeutic Horizons

  2024cites this paper
• CHF6297: a novel potent and selective p38 MAPK inhibitor with robust anti-inflammatory activity and suitable for inhaled pulmonary administration as dry powder

  2024cites this paper
• Bergamot Byproducts: A Sustainable Source to Counteract Inflammation

  2024cites this paper
• Demethylzeylasteral (T-96) Alleviates Allergic Asthma via Inhibiting MAPK/ERK and NF-κB Pathway

  2024cites this paper
• Asynchronous Pattern of MAPKs’ Activity during Aging of Different Tissues and of Distinct Types of Skeletal Muscle

  2024cites this paper
• Unveiling drug-induced side effects through network-based analysis: an update

  2024cites this paper
• Exploring the Mechanisms of the Huangqin Qingfei Decoction in Pneumonia Treatment for Lipopolysaccharide-Induced Mouse Model: A Network Pharmacology Analysis and Experimental Validation

  2024cites this paper
• Nitazoxanide ameliorates OVA-induced airway inflammation in asthmatic mice via p38-MAPK/NFkB and AMPK/STAT3 pathways

  2024cites this paper
• Circular RNA Expression of Peripheral Blood Mononuclear Cells Associated with Risk of Acute Exacerbation in Smoking Chronic Obstructive Pulmonary Disease

  2024cites this paper
• Chronic Allergen Exposure Contributes to Steroid Resistance via Increased Phosphorylation of Glucocorticoid Receptors S226 and p38 MAPK in a Mouse Model of Asthma.

  2023cites this paper
• Mucus hypersecretion in COVID-19 patients: signaling pathway and related targeted therapies

  2023cites this paper
• Bergapten ameliorates combined allergic rhinitis and asthma syndrome after PM2.5 exposure by balancing Treg/Th17 expression and suppressing STAT3 and MAPK activation in a mouse model.

  2023cites this paper
• Smad3‐mediated lncRNA HSALR1 enhances the non‐classic signalling pathway of TGF‐β1 in human bronchial fibroblasts by binding to HSP90AB1

  2023cites this paper
• Inflammaging as a target for healthy ageing.

  2023cites this paper
• Revealing the mechanisms of Arisaema cum Bile on allergic asthma with systematic pharmacology approach-experimental validation.

  2023cites this paper
• Circular RNA DHTKD1 targets miR‑338‑3p/ETS1 axis to regulate the inflammatory response in human bronchial epithelial cells

  2023cites this paper
• Curcumin and PCI-34051 combined treatment ameliorates inflammation and fibrosis by affecting MAP kinase pathway

  2023cites this paper
• Progress in the development of kinase inhibitors for treating asthma and COPD.

  2023cites this paper
• Serum from acupuncture-treated asthmatic rats regulates p38-MAPK activation in airway smooth muscle cells.

  2023cites this paper
• p38 MAPK signaling in chronic obstructive pulmonary disease pathogenesis and inhibitor therapeutics

  2023cites this paper
• Evaluation of the Expression and Localization of the Multifunctional Protein CacyBP/SIP and Elements of the MAPK Signaling Pathway in the Adrenal Glands of Rats with Primary and Secondary Hypertension

  2023cites this paper
• ITGAM-macrophage modulation as a potential strategy for treating neutrophilic Asthma: insights from bioinformatics analysis and in vivo experiments

  2023cites this paper
• Ceramide Nanoliposomes as Potential Therapeutic Reagents for Asthma

  2023cites this paper
• Exploring the Mechanism of Bergamot Essential Oil against Asthma Based on Network Pharmacology and Experimental Verification

  2023cites this paper
• Suhuang Antitussive Capsule Ameliorates Corticosteroid Insensitivity in Cough Variant Asthma Guinea Pigs by Inhibiting p38 MAPK Signal Pathway

  2022cites this paper
• Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD

  2022cites this paper
• Implications of the Immune Landscape in COPD and Lung Cancer: Smoking Versus Other Causes

  2022cites this paper
• Molecular Mechanism Underlying Effects of Wumeiwan on Steroid-Dependent Asthma: A Network Pharmacology, Molecular Docking, and Experimental Verification Study

  2022cites this paper
• Novel Immunomodulatory Therapies for Respiratory Pathologies

  2022cites this paper
• Leonurine attenuates OVA-induced asthma via p38 MAPK/NF-κB signaling pathway.

  2022cites this paper
• Impacts of combined exposure to formaldehyde and PM2.5 at ambient concentrations on airway inflammation in mice.

  2022cites this paper
• Anti-asthmatic miR-224-5p inhibits the FHL1/MAPK pathway to repress airway smooth muscle cell proliferation in a murine model of asthma-like airway inflammation

  2022cites this paper
• Androgen receptor suppresses inflammatory response of airway epithelial cells in allergic asthma through MAPK1 and MAPK14

  2022cites this paper
• The kinase p38α functions in dendritic cells to regulate Th2-cell differentiation and allergic inflammation

  2022cites this paper
• Wogonin attenuates neutrophilic inflammation and airway smooth muscle proliferation through inducing caspase-dependent apoptosis and inhibiting MAPK/Akt signaling in allergic airways.

  2022cites this paper
• Rediscovering the Therapeutic Potential of Agarwood in the Management of Chronic Inflammatory Diseases

  2022influential citation
• Zinc supplement reduces allergic responses through modulating the p38 MAPK pathway activation in an allergic rhinitis mouse model.

  2022cites this paper
• Glucocorticoids

  2021cites this paper
• Evaluation of Toxicity, Bacteriostatic, Analgesic, Anti-Inflammatory, and Antipyretic Activities of Huangqin-Honghua-Pugongying-Jinyinhua Extract

  2021cites this paper
• The Potential for Phospholipids in the Treatment of Airway Inflammation: An Unexplored Solution.

  2021cites this paper
• SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma

  2021cites this paper
• C-Kit+ cells can modulate asthmatic condition via differentiation into pneumocyte-like cells and alteration of inflammatory responses via ERK/NF-ƙB pathway

  2021cites this paper
• PP2A-mTOR-p70S6K/4E-BP1 axis regulates M1 polarization of pulmonary macrophages and promotes ambient particulate matter induced mouse lung injury.

  2021cites this paper
• New Drugs for Airway Diseases

  2021cites this paper
• Adulthood asthma as a consequence of childhood adversity: a systematic review of epigenetically affected genes

  2021cites this paper
• The p38 MAPK Inhibitors and Their Role in Inflammatory Diseases

  2021cites this paper
• Contribution of dipeptidyl peptidase 10 to airway dysfunction in patients with NSAID‐exacerbated respiratory disease

  2021cites this paper
• Corticosteroid resistance in asthma: Cellular and molecular mechanisms.

  2021cites this paper
• Guanosine and uridine alleviate airway inflammation via inhibition of the MAPK and NF-κB signals in OVA-induced asthmatic mice.

  2021cites this paper
• PI3K signalling in chronic obstructive pulmonary disease and opportunities for therapy

  2021cites this paper
• The MAPKinase Signaling and the Stimulatory Protein-1 (Sp1) Transcription Factor Are Involved in the Phototherapy Effect on Cytokines Secretion from Human Bronchial Epithelial Cells Stimulated with Cigarette Smoke Extract

  2021cites this paper
• Targeting Airway Smooth Muscle Hypertrophy in Asthma: An Approach Whose Time Has Come

  2021cites this paper
• COVID-19 and Smoking: What Evidence Needs Our Attention?

  2021cites this paper
• Blood molecular markers associated with COVID‐19 immunopathology and multi‐organ damage

  2020cites this paper
• Role of microRNAs in inflammatory upper airway diseases

  2020cites this paper
• The discovery and evaluation of 3-amino-2(1H)-pyrazinones as a novel series of selective p38α MAP kinase inhibitors.

  2020cites this paper
• Identification and Bioinformatic Analysis of Circular RNA Expression in Peripheral Blood Mononuclear Cells from Patients with Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Mas receptor activation attenuates allergic airway inflammation via inhibiting JNK/CCL2-induced macrophage recruitment.

  2020cites this paper
• Circulating microRNA‐15b‐5p as a biomarker for asthma‐COPD overlap

  2020cites this paper
• Oxidative Stress in Ozone-Induced Chronic Lung Inflammation and Emphysema: A Facet of Chronic Obstructive Pulmonary Disease

  2020cites this paper
• Pulmonary delivery of a p38 α/β MAP kinase inhibitor: bioanalytical method validation and biodistribution in rat plasma and respiratory tissues.

  2020cites this paper
• PRDM15 Is Associated with Risk of Chronic Obstructive Pulmonary Disease in a Rural Population in Chile

  2020cites this paper
• Exposure to diisononyl phthalate promotes atopic march by activating of NF-κB and p38 MAPK.

  2020cites this paper
• Efficacy of statin therapy in chronic obstructive pulmonary disease: a systematic review and meta-analysis from 2008-2019.

  2020cites this paper
• Clinical relevance of understanding mitogen-activated protein kinases involved in asthma

  2020cites this paper
• PI3K inhibitor treatment ameliorates the glucocorticoid insensitivity of PBMCs in severe asthma

  2020cites this paper
• TLR2 favors OVA-induced allergic airway inflammation in mice through JNK signaling pathway with activation of autophagy.

  2020cites this paper
• Mas Receptor Activation Attenuates Allergic Airway In�ammation via Inhibiting JNK/CCL2-induced Macrophage Recruitment

  2020cites this paper
• Comparative transcriptome analysis reveals Dusp1 as a critical regulator of inflammatory response to fly ash particle exposure in mouse.

  2020cites this paper
• Mas Receptor Activation Attenuates Allergic Airway In�ammation via Inhibiting JNK/CCL2-induced Macrophage Recruitment

  2020cites this paper
• Imperatorin alleviates ROS-mediated airway remodeling by targeting the Nrf2/HO-1 signaling pathway

  2020cites this paper
• Sputum transcriptomics: A tool for identifying gene expression underlying mechanistic pathways in severe asthma

  2020cites this paper
• Mas Receptor Activation Attenuates Allergic Airway In�ammation via Inhibiting JNK/CCL2-induced Macrophage Recruitment

  2020cites this paper
• Mas Receptor Activation Attenuates Allergic Airway In�ammation via Inhibiting JNK/CCL2-induced Macrophage Recruitment

  2020cites this paper
• COVID-19 severity is associated with immunopathology and multi-organ damage

  2020cites this paper
• Role of p38-mitogen-activated protein kinase in COPD: pathobiological implications and therapeutic perspectives

  2020cites this paper
• A Topological Data Analysis Network Model of Asthma Based on Blood Gene Expression Profiles

  2019cites this paper
• Gastrodin relieves inflammation injury induced by lipopolysaccharides in MRC‐5 cells by up‐regulation of miR‐103

  2019cites this paper
• Sputum transcriptomics implicates increased p38 signalling activity in severe asthma

  2019cites this paper
• Morse-clustering of a Topological Data Analysis Network Identifies Phenotypes of Asthma Based on Blood Gene Expression Profiles

  2019cites this paper
• Synthesis and p 38 Inhibitory Activity of Some Novel Substituted N , N 1-Diarylurea Derivatives

  2019cites this paper
• LL-37 restored glucocorticoid sensitivity impaired by virus dsRNA in lung.

  2019cites this paper
• Functioning of Organosulfur Compounds from Garlic (Allium sativum Linn) in Targeting Risk Factor-Mediated Atherosclerosis: A Cross Talk Between Alternative and Modern Medicine

  2019cites this paper
• Combined treatment with SB203580 and dexamethasone suppresses non-typeable Haemophilus influenzae-induced Th17 inflammation response in murine allergic asthma.

  2019cites this paper
• S100A12 inhibits fibroblast migration via the receptor for advanced glycation end products and p38 MAPK signaling

  2019cites this paper
• A temperature-dependent conformational shift in p38α MAPK substrate–binding region associated with changes in substrate phosphorylation profile

  2019cites this paper
• Rosiglitazone Improves Glucocorticoid Resistance in a Sudden Sensorineural Hearing Loss by Promoting MAP Kinase Phosphatase-1 Expression

  2019cites this paper
• Synergy of Interleukin (IL)-5 and IL-18 in eosinophil mediated pathogenesis of allergic diseases.

  2019cites this paper
• AZD7624, an Inhaled p38 Inhibitor, Demonstrates Local Lung Inhibition of LPS-Induced TNFα with Minimal Systemic Exposure

  2018cites this paper